These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 5120915)

  • 41. The prevalence of hepatitis C in patients with porphyria cutanea tarda in Stockholm, Sweden.
    Linde Y; Harper P; Floderus Y; Ros AM
    Acta Derm Venereol; 2005; 85(2):164-6. PubMed ID: 15823914
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The use of Carbolen in the treatment of porphyria cutanea tarda. In relation to the article by B.S. Pankov: "Carbolen in the treatment of porphyria cutanea tarda" (Vestnik dermatologii i venerologii, No 4, 1967)].
    Krivosheev BN
    Vestn Dermatol Venerol; 1969 May; 43(5):63-6. PubMed ID: 5368061
    [No Abstract]   [Full Text] [Related]  

  • 43. [Combination of lupus vulgaris and porphyria cutanea tarda].
    Smirnov VS
    Vestn Dermatol Venerol; 1973 Mar; 47(3):66-8. PubMed ID: 4730104
    [No Abstract]   [Full Text] [Related]  

  • 44. Letter: Leser-Trélat sign with porphyria cutanea tarda and malignant hepatoma.
    Harrington CI
    Arch Dermatol; 1976 May; 112(5):730. PubMed ID: 179475
    [No Abstract]   [Full Text] [Related]  

  • 45. [On the pathomorphology of porphyria cutanea tarda].
    Akimochkina RG; Nugmanova KhS
    Vestn Dermatol Venerol; 1966 Sep; 40(9):65-8. PubMed ID: 5998180
    [No Abstract]   [Full Text] [Related]  

  • 46. Porphyria cutanea tarda--association with abnormal iron metabolism.
    Nozicková M; Komárková O; Slezáková L; Smíd A; Votruba M; Dvorák K
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1969; 12(3):361-3. PubMed ID: 5264024
    [No Abstract]   [Full Text] [Related]  

  • 47. [Hepatopathies in porphyria].
    Enríquez de Salamanca R
    Gastroenterol Hepatol; 1999 Feb; 22 Suppl 1():32-7. PubMed ID: 10085600
    [No Abstract]   [Full Text] [Related]  

  • 48. [Lipoid proteinosis and acquired porphyria cutanea tarda].
    Bazex A; Dupré A; Christol B
    Bull Soc Fr Dermatol Syphiligr; 1967; 74(1):21-6. PubMed ID: 5582176
    [No Abstract]   [Full Text] [Related]  

  • 49. High prevalence of hepatitis C virus type 1b in Italian patients with Porphyria cutanea tarda.
    Sampietro M; Fracanzani AL; Corbetta N; Amato M; Mattioli M; Molteni V; Fiorelli G; Fargion S
    Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):543-7. PubMed ID: 9513830
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Some points on threshold effects and action spectra in porphyria cutanea tarda.
    Nozicková-Novotná M
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1982; 25(1):9-41. PubMed ID: 6983111
    [No Abstract]   [Full Text] [Related]  

  • 51. [Disorder of porphyrin metabolism in late porphyria cutanea tarda].
    Smirnov VS
    Vrach Delo; 1968 Jul; 7():141-2. PubMed ID: 5744377
    [No Abstract]   [Full Text] [Related]  

  • 52. Porphyria cutanea tarda in an 8-year-old boy.
    Welland FH; Carlsen RA
    Arch Dermatol; 1969 Apr; 99(4):451-4. PubMed ID: 5769329
    [No Abstract]   [Full Text] [Related]  

  • 53. [Determination of serum ferritin in porphyria cutanea tarda. A reliable sign of hepatic siderosis].
    Gibertini P; Rocchi E; Cassanelli M; Pietrangelo A; Coppini M; Ventura E
    Minerva Med; 1984 Mar; 75(9-10):469-74. PubMed ID: 6709223
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Serum vitamin E, cholesterol and triglyceride concentrations in patients with acute hepatic porphyria and porphyria cutanea tarda].
    Ostrowski J; Kostrzewska E; Błaszczyk M
    Pol Tyg Lek; 1984 Jan; 39(3):87-9. PubMed ID: 6739355
    [No Abstract]   [Full Text] [Related]  

  • 55. [Porphyria cutanea tarda, scleroderma, leukopenia and hemolytic anemia. Clinical, biochemical and pathologic anatomical analysis of an uncommon syndrome].
    Steiner H; Haeger-Aronsen B; Nilsson G; Waldenström J
    Schweiz Med Wochenschr; 1967 Apr; 97(17):538-46. PubMed ID: 5587442
    [No Abstract]   [Full Text] [Related]  

  • 56. [Immunological aspects of porphyria cutanea tarda].
    Köstler E; Seebacher C; Bässler E; Stölzel U; Pätzold K
    Dermatol Monatsschr; 1983; 169(8):498-503. PubMed ID: 6605264
    [No Abstract]   [Full Text] [Related]  

  • 57. Serum antibodies against porphyric hepatocytes in patients with porphyria cutanea tarda and liver disease.
    Baravalle E; Prieto J
    Gastroenterology; 1983 Jun; 84(6):1483-91. PubMed ID: 6840477
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Atypical porphyria cutanea tarda].
    Racouchot J; Turc R; Guilaine J; Chabert H
    Bull Soc Fr Dermatol Syphiligr; 1967; 74(3):367-8. PubMed ID: 6064314
    [No Abstract]   [Full Text] [Related]  

  • 59. [Unusual clinical manifestations of acute intermittent porphyria and its combination with porphyria cutanea tarda].
    Gordon IB; Liakher AV; Kramarenko GA
    Ter Arkh; 1980; 52(9):114-6. PubMed ID: 7434224
    [No Abstract]   [Full Text] [Related]  

  • 60. [Porphyria cutanea tarda in 3 successive generations].
    Nürnberger F
    Med Welt; 1970 Mar; 12():508-10. PubMed ID: 5444241
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.